Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Male Infertility Market, by Treatment
1.4.2 Global Male Infertility Market, by Tests
1.4.3 Global Male Infertility Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Male Infertility Market by Treatment
3.1 Global Assisted Reproductive Technology and Varicocele Surgery Market by Region
3.2 Global Medication Market by Region
Chapter 4. Global Male Infertility Market by Test
4.1 Global DNA Fragmentation Technique Market by Region
4.2 Global Oxidative Stress Analysis Market by Region
4.3 Global Computer Assisted Semen Analysis Market by Region
4.4 Global Microscopic Examination Market by Region
4.5 Global Sperm Agglutination Market by Region
4.6 Global Sperm Penetration Assay Market by Region
4.7 Global Other Test Market by Region
Chapter 5. Global Male Infertility Market by Region
5.1 North America Male Infertility Market
5.1.1 North America Male Infertility Market by Treatment
5.1.1.1 North America Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.1.1.2 North America Medication Market by Country
5.1.2 North America Male Infertility Market by Test
5.1.2.1 North America DNA Fragmentation Technique Market by Country
5.1.2.2 North America Oxidative Stress Analysis Market by Country
5.1.2.3 North America Computer Assisted Semen Analysis Market by Country
5.1.2.4 North America Microscopic Examination Market by Country
5.1.2.5 North America Sperm Agglutination Market by Country
5.1.2.6 North America Sperm Penetration Assay Market by Country
5.1.2.7 North America Other Test Market by Country
5.1.3 North America Male Infertility Market by Country
5.1.3.1 US Male Infertility Market
5.1.3.1.1 US Male Infertility Market by Treatment
5.1.3.1.2 US Male Infertility Market by Test
5.1.3.2 Canada Male Infertility Market
5.1.3.2.1 Canada Male Infertility Market by Treatment
5.1.3.2.2 Canada Male Infertility Market by Test
5.1.3.3 Mexico Male Infertility Market
5.1.3.3.1 Mexico Male Infertility Market by Treatment
5.1.3.3.2 Mexico Male Infertility Market by Test
5.1.3.4 Rest of North America Male Infertility Market
5.1.3.4.1 Rest of North America Male Infertility Market by Treatment
5.1.3.4.2 Rest of North America Male Infertility Market by Test
5.2 Europe Male Infertility Market
5.2.1 Europe Male Infertility Market by Treatment
5.2.1.1 Europe Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.2.1.2 Europe Medication Market by Country
5.2.2 Europe Male Infertility Market by Test
5.2.2.1 Europe DNA Fragmentation Technique Market by Country
5.2.2.2 Europe Oxidative Stress Analysis Market by Country
5.2.2.3 Europe Computer Assisted Semen Analysis Market by Country
5.2.2.4 Europe Microscopic Examination Market by Country
5.2.2.5 Europe Sperm Agglutination Market by Country
5.2.2.6 Europe Sperm Penetration Assay Market by Country
5.2.2.7 Europe Other Test Market by Country
5.2.3 Europe Male Infertility Market by Country
5.2.3.1 Germany Male Infertility Market
5.2.3.1.1 Germany Male Infertility Market by Treatment
5.2.3.1.2 Germany Male Infertility Market by Test
5.2.3.2 UK Male Infertility Market
5.2.3.2.1 UK Male Infertility Market by Treatment
5.2.3.2.2 UK Male Infertility Market by Test
5.2.3.3 France Male Infertility Market
5.2.3.3.1 France Male Infertility Market by Treatment
5.2.3.3.2 France Male Infertility Market by Test
5.2.3.4 Russia Male Infertility Market
5.2.3.4.1 Russia Male Infertility Market by Treatment
5.2.3.4.2 Russia Male Infertility Market by Test
5.2.3.5 Spain Male Infertility Market
5.2.3.5.1 Spain Male Infertility Market by Treatment
5.2.3.5.2 Spain Male Infertility Market by Test
5.2.3.6 Italy Male Infertility Market
5.2.3.6.1 Italy Male Infertility Market by Treatment
5.2.3.6.2 Italy Male Infertility Market by Test
5.2.3.7 Rest of Europe Male Infertility Market
5.2.3.7.1 Rest of Europe Male Infertility Market by Treatment
5.2.3.7.2 Rest of Europe Male Infertility Market by Test
5.3 Asia Pacific Male Infertility Market
5.3.1 Asia Pacific Male Infertility Market by Treatment
5.3.1.1 Asia Pacific Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.3.1.2 Asia Pacific Medication Market by Country
5.3.2 Asia Pacific Male Infertility Market by Test
5.3.2.1 Asia Pacific DNA Fragmentation Technique Market by Country
5.3.2.2 Asia Pacific Oxidative Stress Analysis Market by Country
5.3.2.3 Asia Pacific Computer Assisted Semen Analysis Market by Country
5.3.2.4 Asia Pacific Microscopic Examination Market by Country
5.3.2.5 Asia Pacific Sperm Agglutination Market by Country
5.3.2.6 Asia Pacific Sperm Penetration Assay Market by Country
5.3.2.7 Asia Pacific Other Test Market by Country
5.3.3 Asia Pacific Male Infertility Market by Country
5.3.3.1 India Male Infertility Market
5.3.3.1.1 India Male Infertility Market by Treatment
5.3.3.1.2 India Male Infertility Market by Test
5.3.3.2 China Male Infertility Market
5.3.3.2.1 China Male Infertility Market by Treatment
5.3.3.2.2 China Male Infertility Market by Test
5.3.3.3 Japan Male Infertility Market
5.3.3.3.1 Japan Male Infertility Market by Treatment
5.3.3.3.2 Japan Male Infertility Market by Test
5.3.3.4 South Korea Male Infertility Market
5.3.3.4.1 South Korea Male Infertility Market by Treatment
5.3.3.4.2 South Korea Male Infertility Market by Test
5.3.3.5 Singapore Male Infertility Market
5.3.3.5.1 Singapore Male Infertility Market by Treatment
5.3.3.5.2 Singapore Male Infertility Market by Test
5.3.3.6 Malaysia Male Infertility Market
5.3.3.6.1 Malaysia Male Infertility Market by Treatment
5.3.3.6.2 Malaysia Male Infertility Market by Test
5.3.3.7 Rest of Asia Pacific Male Infertility Market
5.3.3.7.1 Rest of Asia Pacific Male Infertility Market by Treatment
5.3.3.7.2 Rest of Asia Pacific Male Infertility Market by Test
5.4 LAMEA Male Infertility Market
5.4.1 LAMEA Male Infertility Market by Treatment
5.4.1.1 LAMEA Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.4.1.2 LAMEA Medication Market by Country
5.4.2 LAMEA Male Infertility Market by Test
5.4.2.1 LAMEA DNA Fragmentation Technique Market by Country
5.4.2.2 LAMEA Oxidative Stress Analysis Market by Country
5.4.2.3 LAMEA Computer Assisted Semen Analysis Market by Country
5.4.2.4 LAMEA Microscopic Examination Market by Country
5.4.2.5 LAMEA Sperm Agglutination Market by Country
5.4.2.6 LAMEA Sperm Penetration Assay Market by Country
5.4.2.7 LAMEA Other Test Market by Country
5.4.3 LAMEA Male Infertility Market by Country
5.4.3.1 Brazil Male Infertility Market
5.4.3.1.1 Brazil Male Infertility Market by Treatment
5.4.3.1.2 Brazil Male Infertility Market by Test
5.4.3.2 Argentina Male Infertility Market
5.4.3.2.1 Argentina Male Infertility Market by Treatment
5.4.3.2.2 Argentina Male Infertility Market by Test
5.4.3.3 UAE Male Infertility Market
5.4.3.3.1 UAE Male Infertility Market by Treatment
5.4.3.3.2 UAE Male Infertility Market by Test
5.4.3.4 Saudi Arabia Male Infertility Market
5.4.3.4.1 Saudi Arabia Male Infertility Market by Treatment
5.4.3.4.2 Saudi Arabia Male Infertility Market by Test
5.4.3.5 South Africa Male Infertility Market
5.4.3.5.1 South Africa Male Infertility Market by Treatment
5.4.3.5.2 South Africa Male Infertility Market by Test
5.4.3.6 Nigeria Male Infertility Market
5.4.3.6.1 Nigeria Male Infertility Market by Treatment
5.4.3.6.2 Nigeria Male Infertility Market by Test
5.4.3.7 Rest of LAMEA Male Infertility Market
5.4.3.7.1 Rest of LAMEA Male Infertility Market by Treatment
5.4.3.7.2 Rest of LAMEA Male Infertility Market by Test
Chapter 6. Company Profiles
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview